The risk of another heart attack following percutaneous coronary intervention (PCI) was twice as likely to originate from a previously untreated lesion versus the stented lesion, according to a study of a large Swedish cohort published in the Journal of the American Heart Association.

Patients are significantly more likely to die within one year of coronary artery bypass graft (CABG) surgery or PCI in New York state than in England where the procedures are roughly four times cheaper, according to a study in Open Heart.

Temporarily cooling part of the heart during myocardial infarction (MI) and again immediately after angioplasty may reduce damage to the heart, said a cardiologist who participated in the first in-human study of the technique.

Four medical centers have been awarded a cumulative $15 million by the American Heart Association (AHA) as part of an effort to expand current research on vascular disease, the AHA announced in a statement Friday.

Charles E. Chambers, MD, spoke with Cardiovascular Business about the risks of radiation exposure to interventional cardiologists and potential solutions.

DUBLIN, Ohio, January 11, 2018 — Cordis, a Cardinal Health company, and Medinol today announced that the first commercial cases using the EluNIR™ drug-eluting stent (DES) in the United States were performed at New York-Presbyterian Hospital/Columbia University Medical Center in New York City and the Piedmont Heart Institute in Atlanta.

DURHAM, N.C., Jan. 9, 2018 — Micell Technologies, Inc. announced the recent online publication of five-year data from the DESSOLVE I and II trials.

Women undergoing coronary angiography and, if indicated, PCI are more likely to experience severe bleeding and access-site complications than men, but intervening through the radial artery substantially reduced those events, according to data from the MATRIX trial.